Scholarlink

<p>Sepsis management in intensive care units is often hindered by the inability to rapidly localise the primary infection source. While systemic biomarkers such as Procalcitonin (PCT) are widely utilised, their lack of site-specificity remains a significant clinical bottleneck. This study presents a secondary analysis of a prospectively collected, single-centre cohort of 555 patients and investigates the complementary diagnostic value of Pentraxin-3 (PTX3), a locally produced acute-phase reactant, in identifying respiratory-sourced sepsis. We developed an XGBoost-based machine learning framework to compare the diagnostic performance of PTX3, PCT, and C-Reactive Protein (CRP). Individual biomarkers offer limited discriminative power (AUC <InlineEquation ID="IEq1"> <EquationSource Format="TEX">\(\approx 0.62\)</EquationSource> </InlineEquation>), whereas a multi-feature machine learning approach achieves an AUC of 0.865 (95% CI 0.812−0.918; mean cross-validated AUC <InlineEquation ID="IEq2"> <EquationSource Format="TEX">\(= 0.851\)</EquationSource> </InlineEquation>, SD <InlineEquation ID="IEq3"> <EquationSource Format="TEX">\(= 0.031\)</EquationSource> </InlineEquation>). We further employ Explainable Machine Learning techniques specifically SHAP and LIME to provide clinical transparency, demonstrating that PTX3, when combined with soluble CD163 (sCD163) and selected vital signs, provides complementary discriminatory value for pulmonary infection source identification. Sensitivity analyses restricted to biomarker-only features (AUC <InlineEquation ID="IEq4"> <EquationSource Format="TEX">\(= 0.791\)</EquationSource> </InlineEquation>) confirm that this value is not entirely dependent on target-adjacent clinical variables. These findings suggest that a machine-learning-augmented biomarker panel has the potential to support antibiotic stewardship and precision medicine in septic cohorts, pending prospective multicentre validation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Diagnostic evaluation of Pentraxin-3 and its complementary role to Procalcitonin for respiratory sepsis source identification using explainable machine learning

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月15日

查看全文
  • Avichandra Singh Ningthoujam,
  • Avishek Nandi,
  • Niyaz Ahmad Wani

摘要

Sepsis management in intensive care units is often hindered by the inability to rapidly localise the primary infection source. While systemic biomarkers such as Procalcitonin (PCT) are widely utilised, their lack of site-specificity remains a significant clinical bottleneck. This study presents a secondary analysis of a prospectively collected, single-centre cohort of 555 patients and investigates the complementary diagnostic value of Pentraxin-3 (PTX3), a locally produced acute-phase reactant, in identifying respiratory-sourced sepsis. We developed an XGBoost-based machine learning framework to compare the diagnostic performance of PTX3, PCT, and C-Reactive Protein (CRP). Individual biomarkers offer limited discriminative power (AUC \(\approx 0.62\) ), whereas a multi-feature machine learning approach achieves an AUC of 0.865 (95% CI 0.812−0.918; mean cross-validated AUC \(= 0.851\) , SD \(= 0.031\) ). We further employ Explainable Machine Learning techniques specifically SHAP and LIME to provide clinical transparency, demonstrating that PTX3, when combined with soluble CD163 (sCD163) and selected vital signs, provides complementary discriminatory value for pulmonary infection source identification. Sensitivity analyses restricted to biomarker-only features (AUC \(= 0.791\) ) confirm that this value is not entirely dependent on target-adjacent clinical variables. These findings suggest that a machine-learning-augmented biomarker panel has the potential to support antibiotic stewardship and precision medicine in septic cohorts, pending prospective multicentre validation.